Volume 7, Issue 3

September 2012

Special focus: neuroendocrine tumors. Part II

Issue Editor:

9 articles in this issue

Targeting neuroendocrine tumor: mixing standard options with novel therapies
Eric Raymond
Chantal Dreyer
Sandrine Faivre
Editorial 24 August 2012 Pages: 151 - 152
Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors
Sébastien Gaujoux
Alain Sauvanet
Jacques Belghiti
Review 25 August 2012 Pages: 153 - 159
Streptozocin-based chemotherapy is not history in neuroendocrine tumours
Katie Weatherstone
Tim Meyer
Review 17 August 2012 Pages: 161 - 168
New treatment options with cytotoxic agents in neuroendocrine tumours
Pascal Hammel
Olivia Hentic
Philippe Ruszniewski
Review 22 August 2012 Pages: 169 - 172
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies
Annemilaï Tijeras-Raballand
Cindy Neuzillet
Sandrine Faivre
Review 25 August 2012 Pages: 173 - 181
Profiling mTOR pathway in neuroendocrine tumors
S. Cingarlini
M. Bonomi
G. Tortora
Review 14 August 2012 Pages: 183 - 188
Inhibition of mTOR in carcinoid tumors
Simona Grozinsky-Glasberg
Marianne Pavel
Review 12 August 2012 Pages: 189 - 195
Erratum to: Inhibition of mTOR in carcinoid tumors
Simona Grozinsky-Glasberg
Marianne Pavel
Erratum 31 August 2012 Pages: 197 - 197
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma
Andres Morales La Madrid
Nicholas Campbell
Ravi Salgia
Review 12 September 2012 Pages: 199 - 210

Navigation